GRINCAR

2024

1. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

   European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 5-17

2. Adolescent/Adult Sensory Profile for Spanish Population: A Pilot Study of Internal Reliability and Discriminant Validity

   Occupational Therapy in Mental Health, Vol. 40, Núm. 1, pp. 86-98

3. Analysis of the Association between Copy Number Variation and Ventricular Fibrillation in ST-Elevation Acute Myocardial Infarction

   International Journal of Molecular Sciences, Vol. 25, Núm. 5

4. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

   Journal of Cardiac Failure

5. Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study

   Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110

6. Conception, pregnancy, and childbirth from the perspective of transgender men: A meta-ethnography

   Women and Birth, Vol. 37, Núm. 5

7. Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study

   Medicina Clinica, Vol. 163, Núm. 8, pp. e84-e88

8. Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain

   Nefrologia, Vol. 44, Núm. 5, pp. 709-720

9. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response

   Revista Espanola de Cardiologia

10. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

11. Discovery of a cryptic founder variant in MYBPC3 associated with hypertrophic cardiomyopathy by promoting the most frequent natural missplicing events

    European Heart Journal, Vol. 45, Núm. Supplement 1

12. Duelo perinatal: Validar el dolor y reconocer la pérdida

    MUSAS: revista de investigación en mujer, salud y sociedad, Vol. 9, Núm. 1, pp. 1-3

13. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

    European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

14. Encountering the health and social environment after a pregnancy loss: A grounded theory study from male perspective

    Midwifery, Vol. 137

15. European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance

    Transplant International , Vol. 37

16. Focused update 2023 delle linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico

    Giornale italiano di cardiologia (2006), Vol. 25, Núm. 3, pp. 202-213

17. Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

    European Journal of Heart Failure

18. Implementation of a Teledermatology Electronic Consultation Program to Improve the Care of Patients with Inflammatory Bowel Disease

    Telemedicine Reports, Vol. 5, Núm. 1, pp. 12-17

19. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

20. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024

    Journal of Heart and Lung Transplantation, Vol. 43, Núm. 10, pp. 1529-1628.e54